Ondansetron for rectal administration

MYPI1994001305A0Inactive Publication Date: 1994-11-25LAB GLAXOSMITHKLINE SAS
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI1994001305
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
1993-05-25
Filing Date
1994-05-20
Publication Date
1994-11-25
Estimated Expiration
Not applicable · inactive patent
Patent Text Reader

Abstract

THIS INVENTION RELATES TO PHARMACEUTICAL COMPOSITION FOR RECTAL ADMINISTRATION WHICH COMPRISES 1,2,3,9-TETRAHYDRO-9-METHYL-3-[2-METHYL-1H-IMIDAZOL-1-YL)-METHYL]-4H-CARBAZOL-4-ONE, WHICH MAY BE REPRESENTED BY THE FORMULA (I)FORMULA IAND METHOD FOR THE MANUFACTURE OF SUCH COMPOSITIONS AND THEIR USE IN THE TREATMENT OF CONDITIONS MEDIATED THROUGH ACTION OF 5-HYDROXYTRYPTAMINE AT 5-HT3 RECEPTORS.
Need to check novelty before this filing date? Find Prior Art